Pointreau Y, Schick U, Huguet F
Service d'oncologie radiothérapie, institut interrégional de cancérologie, centre Jean-Bernard-clinique Victor-Hugo, 9, rue Beauverger, 72000 Le Mans, France.
Service de radiothérapie, institut de cancérologie et d'hématologie, CHRU Morvan, 2, avenue Foch, 29200 Brest, France.
Cancer Radiother. 2017 Oct;21(6-7):505-509. doi: 10.1016/j.canrad.2017.07.034. Epub 2017 Aug 31.
Induction chemotherapy must be integrated in a global approach for locally advanced head and neck cancer. Its use has theoretical advantages but should not compromise locoregional radiotherapy. Induction chemotherapy is a standard for organ preservation with the use of the TPF scheme to avoid total laryngectomy without compromising survival data. It is more controversial in other locally advanced head and neck cancer because concurrent chemoradiotherapy is the standard of care. It may be an option for patients with significant lymph node invasion to reduce the occurrence of distant metastasis.